Drug Trial Radar · NCT02500316
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Last checked: Nov 20, 2026Latest source record: Apr 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Feb 2014
Primary completion
Nov 2023
Study completion Nov 2023
Sponsor
- Lead sponsor
- OPKO Health, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 16, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 3 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Protocol CP-4-004-OLE (Open Label Extension) is designed as a long-term, open-label extension using single patient use, multi-dose, disposable pre-filled pen.
Conditions
- Growth Hormone Deficiency (GHD)
Interventions
MOD-4023Drug
Once weekly injection of long acting r-hGH (MOD-4023) provided as a solution for injection containing 20 or 50 mg/mL MOD-4023 in a single patient use, multi-dose, disposable pre-filled pen (PEN).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Height VelocityTime frame: 8 years
- Delta Height SDS Every 12 MonthsTime frame: 8 years
Locations
13 sites in 6 countries. Site status is shown where the registry gives one.
Nemours Children's Clinic
Jacksonville, Florida
2DKB
Minsk, Belarus
Children's Hospital "P. A. Kyriakou"
Athens, Greece
Buda Children's Hospital
Budapest, Hungary
Endocrinology Scientific Centre, Institute of Child Endocrinology
Moscow, Russia
Russian Medical Academy of Postgraduate Education
Moscow, Russia
SPGPMA
Saint Petersburg, Russia
SamGMU
Samara, Russia
SBEIHPE
Ufa, Russia
Donetsk Regional Children Clinical Hospital
Donetsk, Ukraine
Institute of Endocrinology
Kiev, Ukraine
Ukrainian Scientific Center of Endocrine Surgery Moh of Ukraine
Kiev, Ukraine
Odessa Regional Children'S Clinical Hospital
Odesa, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.